http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103820362-B

Outgoing Links

Predicate Object
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-50
filingDate 2014-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103820362-B
titleOfInvention A kind of structure of biosynthesizing gentamicinX 2 engineering bacteria and application thereof
abstract The invention belongs to medical art, relate to structure and the application thereof of biosynthesizing gentamicinX 2 genetic engineering bacterium.Utilize microbial molecules genetics technology, make the biosynthesizing key gene inactivation of gentamicin in deep red micromonospora, block gentamicin biosynthetic metabolism stream, directed accumulation gentamicinX 2.The present invention is by construction recombination plasmid pFU503, and pFU503 is imported deep red micromonospora GK1101, technology is knocked out by frame, the function of deactivation <i>genB3</iGreat T.GreaT.GT gene, screening double exchange bacterial strain, tunning detects, and new component qualification, confirms as gentamicinX 2 producing strains.Engineering bacteria constructed by the present invention, stabilization characteristics of genetics, can accumulate gentamicinX 2 in a large number, has filled up domestic and international research blank.Constructed engineering bacteria production technique is simple, and fermentation control is easy, and combined coefficient is high, and Hydrolysis kinetics is convenient, constant product quality, almost reaches clean production boundary, has important commercial application and is worth, can produce great economic benefit.
priorityDate 2014-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID203443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449813004
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416225931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081545
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11159636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426382975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12810388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426198794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14767396

Total number of triples: 34.